COMPANY
Vivreon Biosciences
Funding and NIH signals
- NIH award NIH awarded $1.95M (SBIR commercialization 5SB1AG087756-02, continuation, notice May 12, 2026). NIH RePORTER 5SB1AG087756-02 (May 12, 2026)
Evidence (1 event)
- May 12, 2026 · NIH RePORTER 5SB1AG087756-02
Organization: VIVREON BIOSCIENCES, LLC; City/State: San Diego, CA; Project number: 5SB1AG087756-02; Activity code: SB1; Fiscal year: 2026; Award notice date: 2026-05-12; FY total cost (award amount): 1948898; Administering IC: National Institute on Aging; Project title: Preclinical Characterization of CRAC Channel Inhibitors for the Treatment of Alzheimer's Disease; Organization type: Domestic For-Profits
- May 12, 2026 · NIH RePORTER 5SB1AG087756-02
Timeline
- Grant Government grant — SBIR: $1.95M (annual award, as published), announced May 12, 2026. Agency: NIH/NIA. Source: government award database. source ↗
- Grant Government grant — SBIR: $999,997 (annual award, as published), announced Jul 30, 2025. Agency: NIH/NIAID. Source: government award database. source ↗
- Grant Government grant — SBIR: $1.1M (annual award, as published), announced Jul 8, 2025. Agency: NIH/NIDA. Source: government award database. source ↗
- Grant Government grant — SBIR: $2M (annual award, as published), announced Jun 20, 2025. Agency: NIH/NIA. Source: government award database. source ↗
Funding
- Government grant — SBIR: $1.95M (annual award, as published), announced May 12, 2026. Agency: NIH/NIA. Source: government award database. source ↗
- Government grant — SBIR: $999,997 (annual award, as published), announced Jul 30, 2025. Agency: NIH/NIAID. Source: government award database. source ↗
- Government grant — SBIR: $1.1M (annual award, as published), announced Jul 8, 2025. Agency: NIH/NIDA. Source: government award database. source ↗
- Government grant — SBIR: $2M (annual award, as published), announced Jun 20, 2025. Agency: NIH/NIA. Source: government award database. source ↗
NIH awards 27
- NIH award 1R43AR083315-01A1 FY2024: $306,872 awarded for that fiscal year; activity R43 (SBIR); PI GREENBERG, MILTON L; recipient as written: VIVREON BIOSCIENCES, LLC, San Diego, CA. Development of a Novel Calcium Ch source ↗
- NIH award 2R44AI165096-02 FY2024: $999,997 awarded for that fiscal year; activity R44 (SBIR); PI GREENBERG, MILTON L; recipient as written: VIVREON BIOSCIENCES, LLC, San Diego, CA. Predevelopment of VV8220, a Gut-sel source ↗
- NIH award 4R44DA058467-02 FY2024: $1,401,740 awarded for that fiscal year; activity R44 (SBIR); PI GREENBERG, MILTON L; recipient as written: VIVREON BIOSCIENCES, LLC, San Diego, CA. Development of a Novel Calcium Ch source ↗
- NIH award 5R44CA268541-02 FY2024: $502,010 awarded for that fiscal year; activity R44 (SBIR); PI GREENBERG, MILTON L; recipient as written: VIVREON BIOSCIENCES, LLC, San Diego, CA. IND-Enabling Toxicology for a Novel source ↗
- NIH award 3R44AG061995-03S1 FY2023: $50,000 awarded for that fiscal year; activity R44 (SBIR); PI GREENBERG, MILTON L; recipient as written: VIVREON BIOSCIENCES, LLC, San Diego, CA. Preclinical Characterization of CR source ↗
- NIH award 1R44DA058467-01 FY2023: $319,991 awarded for that fiscal year; activity R44 (SBIR); PI GREENBERG, MILTON L; recipient as written: VIVREON BIOSCIENCES, LLC, San Diego, CA. Development of a Novel Calcium Chan source ↗
- NIH award 5R44AG061995-03 FY2023: $1,223,378 awarded for that fiscal year; activity R44 (SBIR); PI GREENBERG, MILTON L; recipient as written: VIVREON BIOSCIENCES, LLC, San Diego, CA. Preclinical Characterization of C source ↗
- NIH award 1R43HL167426-01 FY2023: $352,030 awarded for that fiscal year; activity R43 (SBIR); PI GREENBERG, MILTON L; recipient as written: VIVREON BIOSCIENCES, LLC, San Diego, CA. Development of a Novel Calcium Chan source ↗
- NIH award 2R44AG061995-02A1 FY2022: $1,276,596 awarded for that fiscal year; activity R44 (SBIR); PI GREENBERG, MILTON L; recipient as written: VIVREON BIOSCIENCES, LLC, San Diego, CA. Preclinical Characterization of source ↗
- NIH award 1R43AR081158-01A1 FY2022: $245,256 awarded for that fiscal year; activity R43 (SBIR); PI GREENBERG, MILTON L; recipient as written: VIVREON BIOSCIENCES, LLC, San Diego, CA. Development of a Novel CRAC Chann source ↗
- NIH award 1R44CA268541-01A1 FY2022: $1,371,030 awarded for that fiscal year; activity R44 (SBIR); PI GREENBERG, MILTON L; recipient as written: VIVREON BIOSCIENCES, LLC, San Diego, CA. IND-Enabling Toxicology for a N source ↗
- NIH award 1R43AI165096-01A1 FY2022: $299,989 awarded for that fiscal year; activity R43 (SBIR); PI GREENBERG, MILTON L; recipient as written: VIVREON BIOSCIENCES, LLC, San Diego, CA. Predevelopment of VV8220, a Gut-s source ↗
- NIH award 1R43AR079968-01A1 FY2021: $252,039 awarded for that fiscal year; activity R43 (SBIR); PI GREENBERG, MILTON L; recipient as written: VIVREON BIOSCIENCES, LLC, San Diego, CA. Predevelopment of VV8321, a Novel source ↗
- NIH award 3R43DA053010-01S1 FY2021: $55,000 awarded for that fiscal year; activity R43 (SBIR); PI GREENBERG, MILTON L; recipient as written: VIVREON BIOSCIENCES, LLC, San Diego, CA. Investigation of Microglial CRAC C source ↗
- NIH award 3R44AG055205-05S1 FY2021: $193,392 awarded for that fiscal year; activity R44 (SBIR); PI GREENBERG, MILTON L; recipient as written: VIVREON BIOSCIENCES, LLC, San Diego, CA. Lead Optimization of CRAC Channel source ↗
- NIH award 1R43DA053010-01 FY2020: $349,967 awarded for that fiscal year; activity R43 (SBIR); PI GREENBERG, MILTON L; recipient as written: VIVREON BIOSCIENCES, LLC, San Diego, CA. Investigation of Microglial CRAC Ch source ↗
- NIH award 3R44CA224454-02S2 FY2020: $249,806 awarded for that fiscal year; activity R44 (SBIR); PI GREENBERG, MILTON L; recipient as written: VIVREON BIOSCIENCES, LLC, San Diego, CA. Predevelopment of VV2003, a Novel source ↗
- NIH award 5R44AG055205-05 FY2020: $1,249,999 awarded for that fiscal year; activity R44 (SBIR); PI GREENBERG, MILTON L; recipient as written: VIVREON BIOSCIENCES, LLC, San Diego, CA. Lead Optimization of CRAC Channel source ↗
- NIH award 3R44CA224454-02S1 FY2020: $224,700 awarded for that fiscal year; activity R44 (SBIR); PI GREENBERG, MILTON L; recipient as written: VIVREON BIOSCIENCES, LLC, San Diego, CA. Predevelopment of VV2003, a Novel source ↗
- NIH award 2R44CA224454-02 FY2019: $1,004,278 awarded for that fiscal year; activity R44 (SBIR); PI GREENBERG, MILTON L; recipient as written: VIVREON BIOSCIENCES, LLC, San Diego, CA. Predevelopment of VV2003, a Novel source ↗
- NIH award 1R43AG061995-01A1 FY2019: $270,902 awarded for that fiscal year; activity R43 (SBIR); PI GREENBERG, MILTON L; recipient as written: VIVREON BIOSCIENCES, LLC, San Diego, CA. Preclinical Characterization of C source ↗
- NIH award 2R44AG055205-04 FY2019: $1,250,000 awarded for that fiscal year; activity R44 (SBIR); PI GREENBERG, MILTON L; recipient as written: VIVREON BIOSCIENCES, LLC, San Diego, CA. Lead Optimization of CRAC Channel source ↗
- NIH award 5R44AG055205-03 FY2018: $745,976 awarded for that fiscal year; activity R44 (SBIR); PI GREENBERG, MILTON L; recipient as written: VIVREON BIOSCIENCES, LLC, San Diego, CA. Lead Optimization of CRAC Channel I source ↗
- NIH award 1R43CA224454-01A1 FY2018: $225,000 awarded for that fiscal year; activity R43 (SBIR); PI GREENBERG, MILTON L; recipient as written: VIVREON BIOSCIENCES, LLC, San Diego, CA. Predevelopment of VV2003, a Novel source ↗
- NIH award 4R44AG055205-02 FY2017: $746,325 awarded for that fiscal year; activity R44 (SBIR); PI GREENBERG, MILTON L; recipient as written: VIVREON BIOSCIENCES, LLC, San Diego, CA. Lead Optimization of CRAC Channel I source ↗
- NIH award 1R43AI134205-01 FY2017: $219,975 awarded for that fiscal year; activity R43 (SBIR); PI GREENBERG, MILTON L; recipient as written: VIVREON BIOSCIENCES, LLC, San Diego, CA. Predevelopment of VV2003, a Novel C source ↗
- NIH award 1R44AG055205-01 FY2016: $222,453 awarded for that fiscal year; activity R44 (SBIR); PI GREENBERG, MILTON L; recipient as written: VIVREON BIOSCIENCES, LLC, San Diego, CA. Lead Optimization of CRAC Channel I source ↗